According to FutureWise analysis the market for High Throughput Screening in 2023 was US$ 18 billion, and is expected to reach US$ 33 billion by 2031 at a CAGR of 8%.
A drug discovery approach known as high-throughput screening (HTS) allows for the automated evaluation of many chemical and/or biological molecules for the presence of a certain biological target. In the pharmaceutical business, high-throughput screening techniques are frequently used to rapidly examine the biological or biochemical activity of a large number of compounds. These techniques make use of robots and automation. High-throughput screening enables a researcher to quickly carry out millions of genetic, chemical, or pharmacological experiments using robotics, liquid handling equipment, data processing/control software, and sensitive detectors.
The number of high-throughput screening devices that are open to the public has significantly increased during the last several years. The scale of these facilities ranges from sizable molecular libraries and probe centre networks to modestly equipped university screening facilities. In order to conduct primary and secondary screening campaigns, these facilities employ both traditional and advanced assay technologies, offering a full way of probe discovery in educational institutions. The market is influenced by the growing use of high-throughput screening for developing drugs, which shortens the time needed to produce a medicine, and by an increase in government financing for the adoption of new technologies like CRISPR-Cas9 and RNAi and artificial intelligence, among others. Additionally, the high throughput screening market is favourably impacted by increases in healthcare spending, disposable income, end-of-use industries, and awareness.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/High-Throughput-Screening/8921
High Throughput Screening Market Segmentation:
By Products and Services
Products
Reagents and Assay Kits
Instruments
Software
Services
By Technology
Cell-Based Assays
Cell Proliferation Assays
Cell Viability Assays
Cell Cytotoxicity Assays
Cell Death Assays
Other Cell-Based Assays
Lab-on-a-Chips
PDMS
Thermopolymers
Glass
Silicon
Paper
Ultra high throughput Screening
Chip-based Screening
Micro-channel Flow Systems
Plateless Systems
Others
Label-Free Technology
SPR
ITC
Others
By Application
Drug Discovery
Medicinal Chemistry
Biology Services
Drug Metabolism and Pharmacokinetics (DMPK)
Chemical Biology Programs
Cellular & Biological Simulation
Disease Modelling
Preclinical Drug Development
Clinical Trials
Cell & Organ-Based Screening
Drug Discovery
Academic Research
Biochemical Screening
Blood and Blood –based Products
Vaccines and Therapeutics
Stem Cells
Biological Active Compound Screening
Target Identification
Primary Screening
Toxicology
Genomics
Diagnostic Application
Precision Medicine
Proteomics
Drug Diagnostics
Precision Medicine
Compound Profiling
Drug Discovery
Cancer/Tumor Profiling
Toxicology
By Detection Method
Mass Spectrometry
Surface-based MALDI-MS
LASI-MS Imaging
Injection-based MS
Others
Chromatography
HIC
HPLC
SEC
HPGC
Others
Calorimetry
Rapid Mass Calorimeter
ITC
Nanocalorimetry
Array Calorimetry
Others
X-ray Diffraction
In situ Crystallization
In meso Crystallization
Crystal X-ray Diffraction
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations (CRO)
Others
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Competitive Landscape in High Throughput Screening Market:
Thermo Fisher Scientific
Agilent Technologies Inc
Danaher
PerkinElmer Inc
Tecan Group Ltd
Axxam S.p.A
Bio-Rad Laboratories Inc
Merck Group KGaA
Hamilton Company
Corning Incorporated
Biotek Instruments Inc
Aurora Biomed Inc
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=8921%20&type=discount
**Objectives of this Study: **
To provide a comprehensive analysis of the High Throughput Screening Market By Products and Services, By Technology, By Application, By Detection Method, By End User and By Region.
To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
The customization services offered are free of charge with the purchase of any license of the report.
You can directly share your requirements/changes to the current table of contents to:
[email protected]
FutureWise Research
Contact Person: Vinay Thaploo.
Email:
[email protected]
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com